Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2226
Tuniu
TOUR
$54M
| $1.85M | ﹤0.01% |
150,710
+29,087
| +24% | +$272K |
2017 Q1
13 quarters
|
|
|
ESXB
2227
DELISTED
Community Bankers Trust Corporation
ESXB
| $1.85M | ﹤0.01% |
337,107
+70,300
| +26% | +$367K |
2016 Q3
15 quarters
|
|
2228
Perrigo
PRGO
$2.13B
| $1.85M | ﹤0.01% |
+33,500
| New | +$1.76M |
2020 Q2
0 quarters
|
|
|
ELVT
2229
DELISTED
Elevate Credit, Inc.
ELVT
| $1.85M | ﹤0.01% |
1,249,955
-241,843
| -16% | -$423K |
2018 Q2
8 quarters
|
|
|
ACGN
2230
DELISTED
Aceragen Inc
ACGN
| $1.85M | ﹤0.01% |
60,763
+24,718
| +69% | +$763K |
2018 Q3
7 quarters
|
|
2231
Ultralife
ULBI
$103M
| $1.84M | ﹤0.01% |
263,064
+28,300
| +12% | +$207K |
2013 Q2
28 quarters
|
|
|
LDL
2232
DELISTED
Lydall, Inc.
LDL
| $1.84M | ﹤0.01% |
135,900
-78,500
| -37% | -$869K |
2013 Q2
28 quarters
|
|
2233
ORIX
IX
$39.7B
| $1.84M | ﹤0.01% |
149,000
-159,000
| -52% | -$1.95M |
2016 Q2
16 quarters
|
|
2234
BlackLine
BL
$1.72B
| $1.83M | ﹤0.01% |
22,100
-69,400
| -76% | -$4.63M |
2019 Q3
3 quarters
|
|
2235
Ridgetech Inc
RDGT
$3.12M
| $1.83M | ﹤0.01% |
37
+9
| +32% | +$684K |
2015 Q1
21 quarters
|
|
|
HARP
2236
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $1.83M | ﹤0.01% |
11,000
-360
| -3% | -$56.2K |
2019 Q3
3 quarters
|
|
2237
Sonoco
SON
$4.82B
| $1.82M | ﹤0.01% |
+34,900
| New | +$1.73M |
2020 Q2
0 quarters
|
|
2238
First Community Corp
FCCO
$304M
| $1.82M | ﹤0.01% |
120,179
+38,039
| +46% | +$569K |
2017 Q4
10 quarters
|
|
|
MFGP
2239
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $1.81M | ﹤0.01% |
330,965
+3,100
| +0.9% | +$17K |
2019 Q4
2 quarters
|
|
2240
Norwegian Cruise Line
NCLH
$7.03B
| $1.81M | ﹤0.01% |
110,334
-1,247,061
| -92% | -$18.3M |
2018 Q4
6 quarters
|
|
2241
Federal Signal
FSS
$6.97B
| $1.8M | ﹤0.01% |
60,700
-123,600
| -67% | -$3.5M |
2017 Q3
11 quarters
|
|
|
RFP
2242
DELISTED
Resolute Forest Products Inc.
RFP
| $1.8M | ﹤0.01% |
851,400
-228,500
| -21% | -$433K |
2014 Q2
24 quarters
|
|
2243
Eagle Bancorp Montana
EBMT
$166M
| $1.79M | ﹤0.01% |
103,174
+22,405
| +28% | +$382K |
2016 Q4
14 quarters
|
|
2244
Sportsman's Warehouse
SPWH
$43.4M
| $1.79M | ﹤0.01% |
+125,528
| New | +$1.18M |
2020 Q2
0 quarters
|
|
2245
Apollo Commercial Real Estate
ARI
$827M
| $1.79M | ﹤0.01% |
182,240
-410,100
| -69% | -$3.48M |
2018 Q1
9 quarters
|
|
2246
DELISTED
AstroNova
ALOT
| $1.77M | ﹤0.01% |
222,206
+29,396
| +15% | +$193K |
2013 Q2
28 quarters
|
|
2247
DELISTED
DallasNews
DALN
| $1.75M | ﹤0.01% |
253,456
+12,218
| +5% | +$77.6K |
2013 Q2
28 quarters
|
|
2248
Madison Square Garden
MSGS
$9.73B
| $1.75M | ﹤0.01% |
11,900
+8,816
| +286% | +$1.46M |
2020 Q1
1 quarter
|
|
2249
Regal Rexnord
RRX
$10.9B
| $1.75M | ﹤0.01% |
20,000
+10,200
| +104% | +$764K |
2018 Q3
7 quarters
|
|
2250
American Assets Trust
AAT
$1.33B
| $1.74M | ﹤0.01% |
62,500
-21,100
| -25% | -$577K |
2020 Q1
1 quarter
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.